NPI: 1447214598 · UNION GAP, WA 98903 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/14/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/14/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 23,902 | $388K |
| 2019 | 21,184 | $417K |
| 2020 | 19,010 | $634K |
| 2021 | 18,568 | $607K |
| 2022 | 18,387 | $632K |
| 2023 | 11,584 | $625K |
| 2024 | 4,507 | $422K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 51,947 | 3,197 | $2.29M |
| A4657 | Syringe, with or without needle, each | 6,528 | 2,509 | $1.29M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 33,062 | 1,914 | $88K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 806 | 410 | $41K |
| J1756 | Injection, iron sucrose, 1 mg | 7,203 | 1,875 | $14K |
| G0008 | Administration of influenza virus vaccine | 182 | 138 | $6K |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,824 | 1,164 | $2K |
| A4913 | Miscellaneous dialysis supplies, not otherwise specified | 423 | 236 | $959.01 |
| 90674 | 109 | 75 | $350.69 | |
| 83970 | 1,166 | 827 | $0.00 | |
| 85041 | 1,168 | 866 | $0.00 | |
| 85048 | 1,170 | 866 | $0.00 | |
| 83540 | 681 | 495 | $0.00 | |
| 90662 | 51 | 31 | $0.00 | |
| 83550 | 609 | 459 | $0.00 | |
| 82728 | 626 | 455 | $0.00 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 75 | 36 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 384 | 208 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 128 | 93 | $0.00 |